Wednesday, 15 February 2012

Ataluren update

Ataluren update - View News Article - Action Duchenne - Fighting for a cure for muscular dystrophy: "PTC Therapeutics is actively involved in preparations for initiating an open-label study for patients with nonsense mutation Duchenne/Becker muscular dystrophy previously treated with ataluren at sites outside the U.S. "

'via Blog this'

No comments:

Post a comment